Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Counteracting neuronal nitric oxide synthase proteasomal degradation improves glucose transport in insulin-resistant skeletal muscle from Zucker fa/fa rats.

Mezghenna K, Leroy J, Azay-Milhau J, Tousch D, Castex F, Gervais S, Delgado-Betancourt V, Gross R, Lajoix AD.

Diabetologia. 2014 Jan;57(1):177-86. doi: 10.1007/s00125-013-3084-9. Epub 2013 Nov 2.

PMID:
24186360
2.

Increased neuronal nitric oxide synthase dimerisation is involved in rat and human pancreatic beta cell hyperactivity in obesity.

Mezghenna K, Pomiès P, Chalançon A, Castex F, Leroy J, Niclauss N, Nadal B, Cambier L, Cazevieille C, Petit P, Gomis R, Berney T, Gross R, Lajoix AD.

Diabetologia. 2011 Nov;54(11):2856-66. doi: 10.1007/s00125-011-2264-8. Epub 2011 Aug 18.

PMID:
21847584
3.

Fatty acid transport proteins chronically relocate to the transverse-tubules in muscle from obese Zucker rats but are resistant to further insulin-induced translocation.

Stefanyk LE, Bonen A, Dyck DJ.

Metabolism. 2013 Sep;62(9):1296-304. doi: 10.1016/j.metabol.2013.04.015. Epub 2013 Jun 3.

PMID:
23743348
4.

Early acarbose treatment ameliorates resistance of insulin-regulated GLUT4 trafficking in obese Zucker rats.

Ledwig D, Müller H, Bischoff H, Eckel J.

Eur J Pharmacol. 2002 Jun 7;445(1-2):141-8.

PMID:
12065205
6.

Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.

Henriksen EJ, Kinnick TR, Teachey MK, O'Keefe MP, Ring D, Johnson KW, Harrison SD.

Am J Physiol Endocrinol Metab. 2003 May;284(5):E892-900. Epub 2003 Jan 7.

7.

Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action.

Kapur S, Bédard S, Marcotte B, Côté CH, Marette A.

Diabetes. 1997 Nov;46(11):1691-700.

PMID:
9356014
8.

Chronic renin inhibition with aliskiren improves glucose tolerance, insulin sensitivity, and skeletal muscle glucose transport activity in obese Zucker rats.

Marchionne EM, Diamond-Stanic MK, Prasonnarong M, Henriksen EJ.

Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R137-42. doi: 10.1152/ajpregu.00448.2011. Epub 2011 Nov 2.

10.

Muscle insulin resistance amended with exercise training: role of GLUT4 expression.

Ivy JL.

Med Sci Sports Exerc. 2004 Jul;36(7):1207-11. Review.

PMID:
15235327
11.
12.

Effects of stevioside on glucose transport activity in insulin-sensitive and insulin-resistant rat skeletal muscle.

Lailerd N, Saengsirisuwan V, Sloniger JA, Toskulkao C, Henriksen EJ.

Metabolism. 2004 Jan;53(1):101-7.

PMID:
14681850
13.
14.

Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: implications for a role of stearoyl-CoA desaturase 1 in insulin resistance.

Voss MD, Beha A, Tennagels N, Tschank G, Herling AW, Quint M, Gerl M, Metz-Weidmann C, Haun G, Korn M.

Diabetologia. 2005 Dec;48(12):2622-30. Epub 2005 Nov 12.

PMID:
16284748
15.

Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.

Dokken BB, Sloniger JA, Henriksen EJ.

Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1188-94. Epub 2005 Jan 25.

16.
17.

Caveolin-3 is involved in the protection of resveratrol against high-fat-diet-induced insulin resistance by promoting GLUT4 translocation to the plasma membrane in skeletal muscle of ovariectomized rats.

Tan Z, Zhou LJ, Mu PW, Liu SP, Chen SJ, Fu XD, Wang TH.

J Nutr Biochem. 2012 Dec;23(12):1716-24. doi: 10.1016/j.jnutbio.2011.12.003. Epub 2012 May 7.

PMID:
22569348
18.
19.

Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance.

Doronzo G, Russo I, Mattiello L, Anfossi G, Bosia A, Trovati M.

Eur J Clin Invest. 2004 Oct;34(10):664-73.

PMID:
15473891
20.

Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats.

Rouru J, Koulu M, Peltonen J, Santti E, Hänninen V, Pesonen U, Huupponen R.

Br J Pharmacol. 1995 Aug;115(7):1182-7.

Supplemental Content

Support Center